How do transfusion services manage patients taking therapies such as anti-CD38 and anti-CD47 known to interfere with red blood cell compatibility testing?
Saved in:
| Title: | How do transfusion services manage patients taking therapies such as anti-CD38 and anti-CD47 known to interfere with red blood cell compatibility testing? |
|---|---|
| Authors: | Murphy MF; NHS Blood and Transplant, Oxford University Hospitals NHS Foundation Trust and the University of Oxford, Oxford, UK., Rajbhandary S; AABB, Bethesda, Maryland, USA., Carayiannis S; AABB, Bethesda, Maryland, USA., Cohn CS; AABB, Bethesda, Maryland, USA.; Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis, Minnesota, USA. |
| Source: | Transfusion [Transfusion] 2024 Jul; Vol. 64 (7), pp. 1217-1222. Date of Electronic Publication: 2024 May 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: American Association Of Blood Banks Country of Publication: United States NLM ID: 0417360 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1537-2995 (Electronic) Linking ISSN: 00411132 NLM ISO Abbreviation: Transfusion Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1537-2995 |
|---|---|
| DOI: | 10.1111/trf.17880 |
